Starting from November 2016, BiomarkerBay collaborates with the Experimental Nephrology group, Department of Internal Medicine, Division of Nephrology, UMCG/RUG.
With this new collaboration, the BiomarkerBay network gains key experts in Nephrology, as the research focus of the group is on renal diseases, including chronic and inflammatory kidney diseases, kidney transplantation, proteinuria and mineral metabolism.
Our assay database also gets richer with biomarker assays related to renal diseases that were developed by Dr. de Borst, Dr. Seelen and Dr. van den Born, including analyses for fibroblast growth factor 23, syndecan 1 and profiling of complement activation in tissue and fluid phase (serum, urine, plasma). The complete list of added assays is available here: Assays_Nephrology_Nov2016).
